Jeff Fairman - 20 Dec 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: VP, Research
Signature: /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol: PCVX
Transactions as of: 20 Dec 2021
Net transactions value: +$8,000
Form type: 4
Filing time: 08 Feb 2022, 16:27:10 UTC
Previous filing: 20 Dec 2021
Next filing: 28 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Options Exercise	$8,000	+4,469	+73%	$1.79^*	10,629	20 Dec 2021	Direct
holding	PCVX	Common Stock						341,227	20 Dec 2021	By Fairman Family Trust
holding	PCVX	Common Stock						50,000	20 Dec 2021	By AF 2020 Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Options Exercise	$0	-4,469	-7.7%	$0.000000	53,626	20 Dec 2021	Common Stock	4,469	$1.79	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option are fully vested and exercisable.